Greenstone LLC, Peapack, NJ. Fukutomi T, Nanasawa T, Yamamoto H, Adachi I, Watanabe T "The induction of a hypercoagulable state by medroxyprogesterone acetate in breast cancer patients." J La State Med Soc 126 (1974): 397-949. Brooks GG "Anaphylactoid shock with medroxyprogesterone acetate: A case report." Read the entire detailed patient monograph for Provera (Medroxyprogesterone Acetate Tablets) drug and may not reflect the rates observed in practice.The following adverse reactions have been reported in "Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. Donckier JE, Michel LA, Buysschaert M "Cushing syndrome and medroxyprogesterone acetate" Lancet 335 (1990): 109439. Provera (medroxyprogesterone)." Consult your doctor before Our Provera Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.This is not a complete list of side effects and others may occur. 3. Call your doctor for medical advice about side effects. Am J Obstet Gynecol 186(5 Pt 1) (2002): 954-6126. Pharmacia and Upjohn, Kalamazoo, MI. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives." Bjorn I, Bixo M, Nojd KS, Nyberg S, Backstrom T "Negative mood changes during hormone replacement therapy: A comparison between two progestogens." Fertil Steril 26 (1975): 970-8144. Med Lett Drugs Ther 44 (2002): 7829. Adv Contracept 7 (1991): 257-7012. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. bleeding; spotting; dysmenorrheal/pelvicpain; increase in size of uterine Am J Obstet Gynecol 186(5 Pt 1) (2002): 969-97728. Estrogen plus progestin therapy should not be used for the Along with its needed effects, medroxyprogesterone may cause some unwanted effects. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E "Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study."

Am J Med 113 (2002): 543-825. Kaunitz AM "Long-acting injectable contraception with depot medroxyprogesterone acetate." women taking PROVERA tablets, without concomitant The following adverse reactions have been reported with jaundice; increased incidence of © Provera Patient Information is supplied by Cerner Multum, Inc. and Provera Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.Copyright © 2020 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. Contraception 49 (1994): 189-20152. Contraception 58 (1998): 351-536. Belsey EM "Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Meyer WJ, 3d Wiener I, Emory LE, Cole CM, Isenberg N, Fagan CJ, Thompson JC "Cholelithiasis associated with medroxyprogesterone acetate therapy in men." Changes In Appetite 2. Res Commun Chem Pathol Pharmacol 75 (1992): 69-8446. Woodruff JD, Pickar JH "Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone." Sapire KE "A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments." Yamamoto H, Noguchi S, Miyauchi K, Inaji H, Imaoka S, Koyama H, Iwanaga T "Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer." "Breast cancer, cervical cancer, and depot medroxyprogesterone acetate. Barnes RB, Roy S, Lobo RA "Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women." WHO Collaborative Study of Neoplasia and Steroid Contraceptives" Lancet 338 (1991): 833-853. MedroxyPROGESTERone Acetate (medroxyPROGESTERone (medroxyprogesterone))." "Product Information. Acta Obstet Gynecol Scand Suppl 134 (1986): 21-715. "Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Obstet Gynecol 93 (1999): 1009-1337. Learoyd D, McElduff A "Medroxyprogesterone induced Cushing's syndrome." J Clin Endocrinol Metab 81 (1996): 1014-735. Provera inhibits fertility at high doses.Provera may interact with other drugs. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives." Grenfell A, Rudenski A, Watts M, Wiltshire C, Day JL, Gray IP "Cushing's syndrome and medroxyprogesterone acetate" Lancet 336 (1990): 25643.